All forward-looking statements contained in this press release speak only as of the date on which they were made. Amylyx undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. View source version on businesswire.com: https://www.businesswire.com/news/home/20220728006051/en/ CONTACT: Media Becky Gohsler Finn Partners (646) 307-6307 Investors Lindsey Allen Amylyx Pharmaceuticals, Inc. (857) 320-6244 KEYWORD: UNITED STATES NORTH AMERICA CANADA MASSACHUSETTS INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY SOURCE: Amylyx Pharmaceuticals, Inc. Copyright Business Wire 2022. PUB: 07/29/2022 09:00 AM/DISC: 07/29/2022 09:02 AM http://www.businesswire.com/news/home/20220728006051/en